PMID- 31344684 OWN - NLM STAT- Publisher LR - 20240227 IS - 1479-6805 (Electronic) IS - 0022-0795 (Linking) DP - 2019 Jul 1 TI - Prenatal ethanol exposure induces susceptibility to premature ovarian insufficiency. LID - JOE-19-0063.R1 [pii] LID - 10.1530/JOE-19-0063 [doi] AB - Prenatal ethanol exposure (PEE) adversely affects the offspring reproductive system. We aimed to confirm the susceptibility to premature ovarian insufficiency (POI) in female PEE offspring and elucidate its intrauterine programming mechanism. The pregnant Wistar female rats were intragastrically administered with 4 g/kgxd of ethanol from gestational day (GD) 9 to 20. Offspring reproductive parameters were detected on GD20, postnatal week (PW) 6, and PW12. The PEE foetuses showed a decreased number of oocytes, increased ovarian cell apoptosis, and upregulated expression levels of ovarian insulin-like growth factor 1 (IGF1) signaling pathway and steroidogenic enzymes. The proportion of atretic follicles in adult rats was increased, while the number of anti-Mullerian hormone-positive antral follicles was decreased. The serum oestradiol (E2) levels were decreased, but the follicle stimulation hormone levels were elevated. The ovarian Igf1 signaling pathway was transformed from activation during puberty to relative inhibition in adulthood, and the expression levels of ovarian steroidogenic enzymes were inhibited in adulthood. Furthermore, we treated the human granulosa cell line KGN with different ethanol concentrations (15, 30, 60, 120 mM) and found that the expression of IGF1 signaling pathway components, 3beta-HSD, and P450arom, as well as the production of E2, was increased. After IGF1 siRNA transfection, P450arom expression and E2 production were downregulated. These results suggest that PEE induces POI susceptibility in adult females, which may be caused by over-activation of the foetal ovarian Igf1 signaling pathway and steroidogenesis under PEE, resulting in accelerated early development of folliculogenesis and depletion of primordial follicles. FAU - Ni, Yuan AU - Ni Y AD - Y Ni, Reproductive Medicine Center, Wuhan University Renmin Hospital, Wuhan, China. FAU - Xu, Dan AU - Xu D AD - D Xu, Department of Pharmacology, Wuhan University, Wuhan, China. FAU - Lv, Feng AU - Lv F AD - F Lv, Department of Pharmacology, Wuhan University, Wuhan, China. FAU - Wan, Yang AU - Wan Y AD - Y Wan, Department of Pharmacology, Wuhan University, Wuhan, China. FAU - Fan, Guanlan AU - Fan G AD - G Fan, Department of Pharmacology, Wuhan University, Wuhan, China. FAU - Zou, Wen AU - Zou W AD - W Zou, Reproductive Medicine Center, Wuhan University Renmin Hospital, Wuhan, China. FAU - Chen, Yunxi AU - Chen Y AD - Y Chen, Reproductive Medicine Center, Wuhan University Renmin Hospital, Wuhan, China. FAU - Pei, Lin-Guo AU - Pei LG AD - L Pei, Department of Pharmacology, Wuhan University, Wuhan, China. FAU - Yang, Jing AU - Yang J AD - J Yang, Reproductive Medicine Center, Wuhan University Renmin Hospital, Wuhan, China. FAU - Wang, Hui AU - Wang H AD - H Wang, Department of Pharmacology, Wuhan University, Wuhan, China. LA - eng PT - Journal Article DEP - 20190701 PL - England TA - J Endocrinol JT - The Journal of endocrinology JID - 0375363 SB - IM EDAT- 2019/07/26 06:00 MHDA- 2019/07/26 06:00 CRDT- 2019/07/26 06:00 PHST- 2019/02/11 00:00 [received] PHST- 2019/07/25 00:00 [accepted] PHST- 2019/07/26 06:00 [entrez] PHST- 2019/07/26 06:00 [pubmed] PHST- 2019/07/26 06:00 [medline] AID - JOE-19-0063.R1 [pii] AID - 10.1530/JOE-19-0063 [doi] PST - aheadofprint SO - J Endocrinol. 2019 Jul 1:JOE-19-0063.R1. doi: 10.1530/JOE-19-0063.